At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TELEHEART: Telotristat Ethyl in a Heart Biomarker Study
In Brief
A Phase 3 clinical trial evaluating Placebo Administration, Questionnaire Administration, and 1 other intervention for Locally Advanced Neuroendocrine Neoplasm and Metastatic Neuroendocrine Neoplasm. Active but no longer recruiting, targeting 79 participants across 1 site.
Detailed Summary
This phase III trial compares the effect of telotristat ethyl and the current standard of care somatostatin analog therapy or somatostatin analog therapy alone in treating patients with neuroendocrine tumor that has spread to other places in the body (metastatic). Telotristat ethyl and somatostatin analog therapy may help to control carcinoid syndrome and carcinoid heart disease.
Study Details
Timeline
Interventions
Given PO
Ancillary studies
Given PO